ALARAweb: Prevention of risks by ionizing radiation
Ionizing radiation are waves or particles with enough energy to produce changes on the atoms and cause ionization. The world health organization describes more than 3600 million of annual procedures implemented on the health sector using ionizing radiations. with the use increases the risk of developing cancer and hematological diseases.
Prevention strategies focused on the use of information obtained from the worker, assisted through a free web platform guarantee a primary prevention and identifies risks, proposes solutions and prevents the birth of new diseases, decreasing the cost to the health system. The integrated team is formed to analyze and solve possible question -free web platform- related to occupational exposure to ionizing radiations
Institutions of health care, according to Fasecolda-Col(https://sistemas.fasecolda.com/rldatos/) and national Insurance of Labor Risk statistics show an increase between the number of companies, number of affiliates and presentation of diseases associated with the use of ionizing radiation.
Scattered radiation can accumulate in living matter and generate changes in DNA. Among the biological effects of ionizing radiation are the changes: stochastic and deterministic in exposed workers. (e.g.: Development cancer and genetic mutations - burns in the skin). https://rpop.iaea.org/RPOP/RPoP/Content-es/InformationFor/Patients/radiation-terms.htm
In such scenarios, dosimeters are needed for effective medical treatment and treatment of exposed persons. To guide the staff in their clinical decisions, with the use of biological markers they are generally applied to examine the changes induced by radiation at different levels; that is, total organism and organ systems.
There is then a negative situation because:
there is no method, that can prevent the occurrence of events early associated to genotoxicity by exposure to low dose of ionizing radiations.
For this reason, the clinics have problems with lawsuits due to exposure of the workers and development of diseases as cancer.
It describes a method for preventing genotoxicity in workers exposed to ionizing radiation within an epidemiological surveillance system of health care institutions.It resolves several problems associated with the presentation of diseases (e.g. cancer, haematologist, cataracts, etc), that can end lawsuits to the company, also to costs assumed by the insurer upon assuming labor disease or indemnities if necessary.Quantifying the risk level of workers exposed, using qualitative investigation, enables real intervention measures to deal with this risk, because includes self-report of health conditions (e.g. pain, health discomfort: blurry vision, signs and symptoms) and questions related to previous work places, years of occupational exposure, training in physical risk.
It describes a method for preventing genotoxicity in workers exposed to ionizing radiation within an epidemiological surveillance system of health care institutions.
It resolves several problems associated with the presentation of diseases (e.g. cancer, haematologist, cataracts, etc), that can end lawsuits to the company, also to costs assumed by the insurer upon assuming labor disease or indemnities if necessary.
Quantifying the risk level of workers exposed, using qualitative investigation, enables real intervention measures to deal with this risk, because includes self-report of health conditions (e.g. pain, health discomfort: blurry vision, signs and symptoms) and questions related to previous work places, years of occupational exposure, training in physical risk.
- Reduce the incidence of NCDs from air pollution, lack of exercise, or unhealthy food
- Enable equitable access to affordable and effective health services
- Prototype
- New application of an existing technology
This method that can prevent the occurrence of events early associated to genotoxicity by exposure to low dose of ionizing radiations. For this reason, the clinics have problems with lawsuits due to exposure of the workers and development of diseases as cancer.
Originality: method with phases:
1 input module: information registration module with: self-report, and dosimetric value.
2 modules of report: output that is computationally assisted and guarantees a quantification of risk. Make predictions.
3 account access: responsible for bringing information to the system.
Is innovation, beacuse mix the qualitative compounts with systems informations and predicts exposition risk of the ionizing radiation
It uses qualitative research as the central axis (from phenomenology and story life).
The technology is computationally assited.
It uses "selfreport", and the mix generate the risk.
- Artificial Intelligence
- Behavioral Design
A pilot test was conducted to find and saturate data that finally designed a series of questions that can be included in a survey to quantify the risk
Use data from life stories (qualitative investigation), that is, from experiences lived from the workplace in terms of exposure to ionizing radiation.
The questions are obtained from the worker and their answers are valued to identify the risk
Axial and open transcription of data was made to arrive at the construction of the self report
It is approached from phenomenology to model short-term changes that will influence long-term.
- Urban Residents
- Argentina
- Colombia
- Argentina
- Colombia
Now: Pilot
One year: Half of the workers exposed in Colombia: 6,000 workers
Two years: Total of exposed in Colombia and Argentina: 20,000
Five years: Several countries of the world: 1,000,000 workers
Clear objectives of risk mitigation and control of diseases associated with the use of ionizing radiation within national and neighboring surveillance systems.
Initially and next year, be aligned with the SDGs, the Public Health Ten-Year Plan and the Occupational Cancer Control Plan, which aims to reduce the presentation of events by ionizing radiation by up to 50%.
The goals in five years is to be about the design and implementation of labor surveys of exposed workers.
Protecting and identifying risks in a working population of more than one million workers worldwide.
Currently: publicize, socialize, have strategic partners.
Next year: know managers of insurers of health institutions to sell the product.
Five years: have financial strength to cover other continents
Publicity: web, social network (inicially)
Know managers: attend conferences, work presentations,workshop, etc.
Financial: partnership with insurance company
- Other e.g. part of a larger organization (please explain below)
It is academic investigation
At this time, four investigators.
1 Microbiologist: Am I. With master degree in public health, and occupational health.
2. Students: Chemestry semester VII
3. Teacher: Proffesor PhD, with experience in qualitative investigation.
The experience in the sector( health and occupational health), they make sure that the criteria for the solution are met.
The consolidation of a good work team.
The academic instruction and education experience they make a reason good.
At this time, a investigation group with Distrital University and Nariño University.
Key Partners
Professionals with skills in clinical management: Doctors-Microbiologist (advisory and processing)
Key Activities
It is possible to intervene with the medical surveillance program of the companies where the periodic examinations are included.
It is integrated with the Hazard matrix to give legal compliance in companies.
Advisory and initial professional accompaniment in the handling prevention method.
Key Resources
Physical: Place, areas of the company (warehouse, reception, processing, consulting, basement, etc)
Intellectual: Human resource, intellectual, brands, patents, improvements
Consulting: Human resource (Doctors, Microbiologist, Chemical)
Financial: Financial loans, capital investment
Value Proposition
It is personalized and offers the possibility of early preventing genotoxicity
Benefit: Provides legal compliance.
Helps prevent diseases in workers.
It is an easy service to take, less invasive.
Customer Relationships
Scientific: Advisory according to alters of the risk factor.
Commercial: Financing, business proposal.
Legal: Accompaniment in compliance.
Channels
Training and consulting on product support, as follows:
Clinical: (Advisory and orientation)
Legal: Compliance with labor standards (Law)
Customer Segments
Health: Health care institutions and insurance.
Cost Structure
Variable costs: Customer management.
Fixed costs: Human resource.
Fixed costs: Technical supplies.
Revenue Streams
Publicity: Social networks, Google, web.
Trade: Direct sale.
Mobile: Sales from the app.
Monetizing the advice.
Initially of a spin-off type company, with market pull technology management model.
If there are risks, there is the possibility of something happening: it is the consequence of the use of the product (commercialize) or not use (another product may come to market)
Possibility is the probability that the product is marketed in the market.
Uncertainty is the range of possible outcomes: gains or losses with the method.
Gains:
Avoid lawsuits for sick pay or occupational disease
Meets legal requirements
Unexpected gain: Less disability. Avoid paying recognition derived from occupational exposure
Positive consequence as positioning in the market
Pain relievers:
It includes advice (consulting) on prevention based on the requirements of the labor law
Meets legal requirements, for example, methods of prevention of occupational diseases
It has a prevention tool in case it is exposed to a demand
It can help prevent (early detection) the appearance of diseases associated with the use of radiation
Gain creators:
It has safer workers; the method helps prevent a possible disease
Improve worker productivity and performance (use an early detection method)
If you use a prevention method, you reduce the legal risk by lawsuits, as it meets legal requirements for prevention
It has saving time and money for demands
It makes life easier within the company with respect to risk control
The product is the best on the market because it allows planning, preventing, monitoring and measuring risk
- Business model
- Technology
- Funding and revenue model
- Talent or board members
- Legal
- Monitoring and evaluation
- Other
Alliance with risk insurer, for example in Colombia.
Yes, in Colombia there are nine companies, they dedicate to occupational health care. In southamerica, there are companies "insurer" the labor risk that is intersting in this process.
NA
I would like to be considered for this topic because this methodology has a preventive focus.
Use an existing technology that has not been used in this type of people, the improvement, validates it to be applied and solve the negative situation (problem).
NA
NA
NA
NA
ALARWEB